171 related articles for article (PubMed ID: 15710499)
1. Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration.
Demana PH; Davies NM; Hook S; Rades T
J Control Release; 2005 Mar; 103(1):45-59. PubMed ID: 15710499
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of ovalbumin into ISCOMs and related colloidal particles prepared by the lipid film hydration method.
Demana PH; Davies NM; Berger B; Rades T
Int J Pharm; 2004 Jul; 278(2):263-74. PubMed ID: 15196631
[TBL] [Abstract][Full Text] [Related]
3. A comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by lipid-film hydration and dialysis.
Demana PH; Davies NM; Berger B; Vosgerau U; Rades T
J Pharm Pharmacol; 2004 May; 56(5):573-80. PubMed ID: 15142333
[TBL] [Abstract][Full Text] [Related]
4. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method.
Demana PH; Davies NM; Vosgerau U; Rades T
Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138
[TBL] [Abstract][Full Text] [Related]
5. On the preparation, microscopic investigation and application of ISCOMs.
Myschik J; Lendemans DG; McBurney WT; Demana PH; Hook S; Rades T
Micron; 2006; 37(8):724-34. PubMed ID: 16750912
[TBL] [Abstract][Full Text] [Related]
6. A novel method for preparing immune stimulating complexes (ISCOMs) by hydration of freeze-dried lipid matrix.
Liang M; Toth I; Davies NM
Eur J Pharm Biopharm; 2008 Mar; 68(3):840-5. PubMed ID: 18182279
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of cationic derivatives of Quil A and the preparation of cationic immune-stimulating complexes (ISCOMs).
Pham HL; Ross BP; McGeary RP; Shaw PN; Davies NM
Int J Pharm; 2009 Jul; 376(1-2):123-33. PubMed ID: 19375488
[TBL] [Abstract][Full Text] [Related]
8. Preparation of immuno-stimulating complexes (ISCOMs) by ether injection.
Pham HL; Shaw PN; Davies NM
Int J Pharm; 2006 Mar; 310(1-2):196-202. PubMed ID: 16413713
[TBL] [Abstract][Full Text] [Related]
9. Immuno-stimulating complexes prepared by ethanol injection.
Lendemans DG; Myschik J; Hook S; Rades T
J Pharm Pharmacol; 2005 Jun; 57(6):729-33. PubMed ID: 15969927
[TBL] [Abstract][Full Text] [Related]
10. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes.
Copland MJ; Rades T; Davies NM
Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704
[TBL] [Abstract][Full Text] [Related]
11. On the dilution behaviour of immuno-stimulating complexes (ISCOMs).
Lendemans DG; Egert AM; Myschik J; Hook S; Rades T
Pharmazie; 2006 Aug; 61(8):689-95. PubMed ID: 16964712
[TBL] [Abstract][Full Text] [Related]
12. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics.
Tewa-Tagne P; Briançon S; Fessi H
Int J Pharm; 2006 Nov; 325(1-2):63-74. PubMed ID: 16872767
[TBL] [Abstract][Full Text] [Related]
13. Cage-like complexes formed by DOTAP, Quil-A and cholesterol.
Lendemans DG; Egert AM; Hook S; Rades T
Int J Pharm; 2007 Mar; 332(1-2):192-5. PubMed ID: 17049770
[TBL] [Abstract][Full Text] [Related]
14. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
[TBL] [Abstract][Full Text] [Related]
15. Cationic cage-like complexes formed by DC-cholesterol, Quil-A, and phospholipid.
Lendemans DG; Myschik J; Hook S; Rades T
J Pharm Sci; 2005 Aug; 94(8):1794-807. PubMed ID: 15986471
[TBL] [Abstract][Full Text] [Related]
16. Influence of Quil A on liposomal membranes.
Paepenmüller T; Müller-Goymann CC
Int J Pharm; 2014 Nov; 475(1-2):138-46. PubMed ID: 25107288
[TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part I: Physicochemical characterisation.
Myschik J; Eberhardt F; Rades T; Hook S
J Drug Target; 2008 Apr; 16(3):213-23. PubMed ID: 18365883
[TBL] [Abstract][Full Text] [Related]
18. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
19. Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation.
Tewa-Tagne P; Briançon S; Fessi H
Eur J Pharm Sci; 2007 Feb; 30(2):124-35. PubMed ID: 17150339
[TBL] [Abstract][Full Text] [Related]
20. Confocal Raman microscopy to probe content uniformity of a lipid based powder for inhalation: a quality by design approach.
Schoenherr C; Haefele T; Paulus K; Francese G
Eur J Pharm Sci; 2009 Aug; 38(1):47-54. PubMed ID: 19501161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
